1887

Abstract

We successfully constructed a full-length cDNA infectious clone of the encephalomyocarditis virus (EMCV) HB10 strain and obtained a partially attenuated rEMCV-C virus with a shorter poly(C) tract. Our results showed that the length of the EMCV-HB10 poly(C) tract was related to the pathogenicity of the EMCV-HB10 strain . Using pEMCV-C as the backbone, we constructed the novel viral vector pC-MCS-∆2A by inserting a cDNA fragment containing a 127 amino acid deletion in the 2A protein, a primary cleavage cassette, a FLAG tag and a multiple cloning site (MCS) at the junction of VP1 and ∆2A. Additionally, the enhanced green fluorescent protein () gene was cloned into the MCS of pC-MCS-∆2A to test its capacity to express foreign proteins. Insertion of the gene did not affect viral replication, and a decrease in EGFP expression was observed within five serial passages. Furthermore, we found that rC-EGFP-∆2A was avirulent induced neutralizing antibody production and conferred protective immune responses against lethal challenge with EMCV in mice. Taken together, our results demonstrated that we had constructed an attenuated live vector based on an EMCV-HB10 strain with two modified critical virulence factors (the poly(C) tract and 2A protein) that could be used as a candidate live vaccine and a potential live viral vector for foreign antigen delivery.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000541
2016-09-01
2020-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2280.html?itemId=/content/journal/jgv/10.1099/jgv.0.000541&mimeType=html&fmt=ahah

References

  1. Altmeyer R., Escriou N., Girard M., Palmenberg A., van der Werf S.. 1994; Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc Natl Acad Sci U S A91:9775–9779 [CrossRef][PubMed]
    [Google Scholar]
  2. Altmeyer R., Girard M., van der Werf S., Mimic V., Seigneur L., Saron M. F.. 1995; Attenuated Mengo virus: a new vector for live recombinant vaccines. J Virol69:3193–3196[PubMed]
    [Google Scholar]
  3. Andino R., Silvera D., Suggett S. D., Achacoso P. L., Miller C. J., Baltimore D., Feinberg M. B.. 1994; Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science265:1448–1451 [CrossRef][PubMed]
    [Google Scholar]
  4. Aubry F., Nougairède A., Gould E. A., de Lamballerie X.. 2015; Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective. Antiviral Res114:67–85 [CrossRef][PubMed]
    [Google Scholar]
  5. Bai J., Jiang K., Zhang G., Wang X., Li Y., Jiang P.. 2012; Pathogenicity and molecular analysis of an encephalomyocarditis virus isolate from mideastern China. Can J Vet Res76:157–160[PubMed]
    [Google Scholar]
  6. Balasuriya U. B. R., Zhang J., Go Y. Y., MacLachlan N. J.. 2014; Experiences with infectious cDNA clones of equine arteritis virus: Lessons learned and insights gained. Virology462-463:388–403 [CrossRef]
    [Google Scholar]
  7. Binder J. J., Hoffman M. A., Palmenberg A. C.. 2003; Genetic stability of attenuated mengovirus vectors with duplicate primary cleavage sequences. Virology312:481–494 [CrossRef][PubMed]
    [Google Scholar]
  8. Buenz E. J., Howe C. L.. 2006; Picornaviruses and cell death. Trends Microbiol14:28–36 [CrossRef][PubMed]
    [Google Scholar]
  9. Carocci M., Bakkali-Kassimi L.. 2012; The encephalomyocarditis virus. Virulence3:351–367 [CrossRef][PubMed]
    [Google Scholar]
  10. Carocci M., Cordonnier N., Huet H., Romey A., Relmy A., Gorna K., Blaise-Boisseau S., Zientara S., Kassimi L. B.. 2011; Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis. J Virol85:10741–10754 [CrossRef][PubMed]
    [Google Scholar]
  11. Cerutis D. R., Bruner R. H., Thomas D. C., Giron D. J.. 1989; Tropism and histopathology of the D, B, K, and MM variants of encephalomyocarditis virus. J Med Virol29:63–69 [CrossRef][PubMed]
    [Google Scholar]
  12. Cui T., Sankar S., Porter A. G.. 1993; Binding of encephalomyocarditis virus RNA polymerase to the 3′-noncoding region of the viral RNA is specific and requires the 3′-poly(A) tail. J Biol Chem268:26093–26098[PubMed]
    [Google Scholar]
  13. Donnelly M. L., Luke G., Mehrotra A., Li X., Hughes L. E., Gani D., Ryan M. D.. 2001; Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip'. J Gen Virol82:1013–1025 [CrossRef][PubMed]
    [Google Scholar]
  14. Duke G. M., Osorio J. E., Palmenberg A. C.. 1990; Attenuation of Mengo virus through genetic engineering of the 5′ noncoding poly(C) tract. Nature343:474–476 [CrossRef][PubMed]
    [Google Scholar]
  15. Feng R., Zhang H., Wei J., Li X., Xie J., Li M., Qiao Z., Feng Y., Ma Z.. 2015; Isolation, molecular and phylogenetic analysis of encephalomyocarditis virus strain GS01 in China. Infect Genet Evol30:19–26 [CrossRef][PubMed]
    [Google Scholar]
  16. Grobler D. G., Raath J. P., Braack L. E., Keet D. F., Gerdes G. H., Barnard B. J., Kriek N. P., Jardine J., Swanepoel R.. 1995; An outbreak of encephalomyocarditis-virus infection in free-ranging African elephants in the Kruger National Park. Onderstepoort J Vet Res62:97–108[PubMed]
    [Google Scholar]
  17. Hahn H., Palmenberg A. C.. 1995; Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J Virol69:2697–2699[PubMed]
    [Google Scholar]
  18. Huang L., Liu Q., Zhang L., Zhang Q., Hu L., Li C., Wang S., Li J., Zhang Y. et al. 2015; Encephalomyocarditis virus 3C protease relieves TRAF family member-associated NF-κB activator (TANK) inhibitory effect on TRAF6-mediated NF-κB signaling through cleavage of TANK. J Biol Chem290:27618–27632 [CrossRef][PubMed]
    [Google Scholar]
  19. Kirkland P. D., Gleeson A. B., Hawkes R. A., Naim H. M., Boughton C. R.. 1989; Human infection with encephalomyocarditis virus in New South Wales. Med J Aust151:176–178[PubMed]
    [Google Scholar]
  20. LaRue R., Myers S., Brewer L., Shaw D. P., Brown C., Seal B. S., Njenga M. K.. 2003; A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques. J Virol77:9136–9146 [CrossRef][PubMed]
    [Google Scholar]
  21. Li J., Guo D., Huang L., Yin M., Liu Q., Wang Y., Yang C., Liu Y., Zhang L. et al. 2014; The interaction between host Annexin A2 and viral Nsp9 is beneficial for replication of porcine reproductive and respiratory syndrome virus. Virus Res189:106–113 [CrossRef][PubMed]
    [Google Scholar]
  22. Lin W., Liu Y., Cui S., Liu H.. 2012; Isolation, molecular characterization and phylogenetic analysis of porcine encephalomyocarditis virus strain HB10 in China. Infect Genet Evol12:1324–1327 [CrossRef][PubMed]
    [Google Scholar]
  23. Mattion N. M., Reilly P. A., DiMichele S. J., Crowley J. C., Weeks-Levy C.. 1994; Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. J Virol68:3925–3933[PubMed]
    [Google Scholar]
  24. Miller J. P., Geng Y., Ng H. L., Yang O. O., Krogstad P.. 2009; Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector. Vaccine27:3992–4000 [CrossRef][PubMed]
    [Google Scholar]
  25. Mueller S., Wimmer E.. 1998; Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames. J Virol72:20–31[PubMed]
    [Google Scholar]
  26. Palmenberg A. C., Kirby E. M., Janda M. R., Drake N. L., Duke G. M., Potratz K. F., Collett M. S.. 1984; The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res12:2969–2985 [CrossRef][PubMed]
    [Google Scholar]
  27. Psalla D., Psychas V., Spyrou V., Billinis C., Papaioannou N., Vlemmas I.. 2006; Pathogenesis of experimental encephalomyocarditis: a histopathological, immunohistochemical and virological study in mice. J Comp Pathol135:142–145 [CrossRef][PubMed]
    [Google Scholar]
  28. Seago J., Juleff N., Moffat K., Berryman S., Christie J. M., Charleston B., Jackson T.. 2013; An infectious recombinant foot-and-mouth disease virus expressing a fluorescent marker protein. J Gen Virol94:1517–1527 [CrossRef][PubMed]
    [Google Scholar]
  29. Takeda M., Hirasawa K., Doi K.. 1991; Lesions in the central nervous system of DBA/2 mice infected with the D variant of encephalomyocarditis virus (EMC-D). J Vet Med Sci53:1013–1017 [CrossRef][PubMed]
    [Google Scholar]
  30. Van der Ryst E., Nakasone T., Habel A., Venet A., Gomard E., Altmeyer R., Girard M., Borman A. M.. 1998; Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes. Res Virol149:5–20 [CrossRef][PubMed]
    [Google Scholar]
  31. Verlinde J. D., Van Tongeren H. A.. 1953; Human infection with viruses of the Columbia SK group. Arch Gesamte Virusforsch5:217–227 [CrossRef][PubMed]
    [Google Scholar]
  32. Yoon J. W., Jun H. S.. 2006; Viruses cause type 1 diabetes in animals. Ann N Y Acad Sci1079:138–146 [CrossRef][PubMed]
    [Google Scholar]
  33. Yuan W., Song Q., Zhang X., Zhang L., Sun J.. 2014; Isolation and molecular analysis of porcine encephalomyocarditis virus strain BD2 from northern China. Infect Genet Evol21:303–307 [CrossRef][PubMed]
    [Google Scholar]
  34. Zeng J., Chen X., Dai J., Zhao X., Xin G., Su Y., Wang G., Li R., Yan Y. et al. 2013; An attenuated coxsackievirus b3 vector: a potential tool for viral tracking study and gene delivery. PLoS One8:e83753 [CrossRef][PubMed]
    [Google Scholar]
  35. Zhang G. Q., Ge X. N., Guo X., Yang H. C.. 2007a; Genomic analysis of two porcine encephalomyocarditis virus strains isolated in China. Archives of Virology152:1209–1213 [CrossRef]
    [Google Scholar]
  36. Zhang J. L., Xin-Na G. E., Liang M. A., Chen Y. H., Zha Z. L., Guo X., Yang H. C.. 2007b; Serological survey of EMCV infection in pigs on large-scale pig farms in China 2005-2006. J Veterinary Med1:7–9
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000541
Loading
/content/journal/jgv/10.1099/jgv.0.000541
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error